Cargando…

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC

Detalles Bibliográficos
Autores principales:	Abudoureyimu, Mubalake, Lai, Yongting, Tian, Chuan, Wang, Ting, Wang, Rui, Chu, Xiaoyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215169/ https://www.ncbi.nlm.nih.gov/pubmed/32432043 http://dx.doi.org/10.3389/fonc.2020.00701

Ejemplares similares

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2020)

Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2019)

Oncolytic Viral Therapy for Mesothelioma
por: Pease, Daniel F., et al.
Publicado: (2017)

Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020)

Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
por: O’Cathail, Sean M., et al.
Publicado: (2017)

Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
por: Liu, Xing, et al.
Publicado: (2020)

Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Tian, Chuan, et al.
Publicado: (2021)

Correction to: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Tian, Chuan, et al.
Publicado: (2021)

Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021)

Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)

Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014)

Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020)

Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)

A Renaissance for Oncolytic Adenoviruses?
por: Blanchette, Paola, et al.
Publicado: (2023)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2015)

Going viral: a review of replication-selective oncolytic adenoviruses
por: Larson, Christopher, et al.
Publicado: (2015)

Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation
por: Mao, Li-jun, et al.
Publicado: (2020)

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
por: Xie, Daoyuan, et al.
Publicado: (2023)

Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
por: Hajeri, Praveensingh B., et al.
Publicado: (2020)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018)

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines
por: Tai, Lee-Hwa, et al.
Publicado: (2014)

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers
por: Scanlan, Hayle, et al.
Publicado: (2022)

Oncolytic Viruses as Anticancer Vaccines
por: Woller, Norman, et al.
Publicado: (2014)

Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022)

Oncolytic adenovirus-mediated therapy for prostate cancer
por: Sweeney, Katrina, et al.
Publicado: (2016)

Photoactivatable oncolytic adenovirus for optogenetic cancer therapy
por: Hagihara, Yasuko, et al.
Publicado: (2020)

Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and anti-tumor efficacy
por: Cherry, Tiffani, et al.
Publicado: (2010)

Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
por: Capasso, Cristian, et al.
Publicado: (2015)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2020)

Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses
por: Núñez-Manchón, Estela, et al.
Publicado: (2021)

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
por: Zhang, Bin, et al.
Publicado: (2021)

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
por: Meyers, Daniel E., et al.
Publicado: (2017)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014)

Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2iol3piehk0c3gv8a7rt6ln387